Cargando…
TILRR Steers Interleukin-1 Signaling: Co-Receptor Provides Context and a Therapeutic Target
[Figure: see text]
Autor principal: | Mac Gabhann, Feilim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034432/ https://www.ncbi.nlm.nih.gov/pubmed/30062159 http://dx.doi.org/10.1016/j.jacbts.2017.06.001 |
Ejemplares similares
-
Targeting Neuropilin-1 to Inhibit VEGF Signaling in Cancer: Comparison of Therapeutic Approaches
por: Gabhann, Feilim Mac, et al.
Publicado: (2006) -
Targeting neuropilins as a viable SARS‐CoV‐2 treatment
por: Sarabipour, Sarvenaz, et al.
Publicado: (2021) -
Wisdom of crowds in computational biology
por: Papin, Jason A., et al.
Publicado: (2019) -
TILRR (Toll-like Interleukin-1 Receptor Regulator), an Important Modulator of Inflammatory Responsive Genes, is Circulating in the Blood
por: Kashem, Mohammad Abul, et al.
Publicado: (2021) -
The blossoming of methods and software in computational biology
por: Mac Gabhann, Feilim, et al.
Publicado: (2023)